CAR T Cell Therapy Biomanufactured by Cellares Infused Into First Two Patients
The scalable biomanufacturing of autologous products to supply thousands of patients per year can potentially be achieved with minimal capital investment and a low cost of goods. The post CAR T Cell Therapy Biomanufactured by Cellares Infused Into First Two Patients appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Source
Read the full article at Genengnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.